Literature DB >> 9213012

Circadian variation in bone resorption is not related to serum cortisol.

A Schlemmer1, C Hassager, P Alexandersen, C Fledelius, B J Pedersen, I O Kristensen, C Christiansen.   

Abstract

Serum osteocalcin, serum procollagen type I carboxyterminal propeptide (sPICP), and the urinary excretion of pyridinium crosslinks (biochemical markers of bone formation and resorption) all exhibit a circadian variation with a peak during the night. This study was performed to investigate the influence of the endogenous circadian rhythm in cortisol on the biochemical markers of bone turnover. Participants included 11 patients substituted with hydrocortisone due to either hypopituitarism (n = 7) or bilateral adrenalectomy (n = 4). Their daily tablet intake of hydrocortisone was divided in four equal doses in order to abrogate the known circadian variation in cortisol. 24 healthy postmenopausal women served as controls. The study design was performed over 24 h, with blood samples taken every 3 h, and urine collected in 3 h aliquots. Urinary pyridinium crosslinks (Pyr/ Cr, D-Pyr/Cr), serum osteocalcin (sOC), and serum PICP were measured. Patients without a circadian variation in cortisol had normal circadian variation in the urinary excretion of pyridinium crosslinks and sPICP, but no circadian rhythm in serum osteocalcin. We conclude that the etiology of the circadian rhythm in the biochemical markers of bone turnover is still unknown. This study indicates that the circadian variation in sOC can be controlled by the endogenous circadian variation in serum cortisol, whereas this hormone does not control the circadian variation in either the serum PICP or the urinary excretion in pyridinium crosslinks.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9213012     DOI: 10.1016/s8756-3282(97)00039-2

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  12 in total

Review 1.  An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice.

Authors:  D J Leeming; P Alexandersen; M A Karsdal; P Qvist; S Schaller; L B Tankó
Journal:  Eur J Clin Pharmacol       Date:  2006-08-16       Impact factor: 2.953

Review 2.  Fast and slow bone losers. Relevance to the management of osteoporosis.

Authors:  S Hough
Journal:  Drugs Aging       Date:  1998       Impact factor: 3.923

Review 3.  Obstructive sleep apnea and metabolic bone disease: insights into the relationship between bone and sleep.

Authors:  Christine M Swanson; Steven A Shea; Katie L Stone; Jane A Cauley; Clifford J Rosen; Susan Redline; Gerard Karsenty; Eric S Orwoll
Journal:  J Bone Miner Res       Date:  2015-02       Impact factor: 6.741

4.  Bone turnover is altered during 72 h of sleep restriction: a controlled laboratory study.

Authors:  Jeffery S Staab; Tracey J Smith; Marques Wilson; Scott J Montain; Erin Gaffney-Stomberg
Journal:  Endocrine       Date:  2019-04-26       Impact factor: 3.633

Review 5.  The importance of the circadian system & sleep for bone health.

Authors:  Christine M Swanson; Wendy M Kohrt; Orfeu M Buxton; Carol A Everson; Kenneth P Wright; Eric S Orwoll; Steven A Shea
Journal:  Metabolism       Date:  2017-12-09       Impact factor: 8.694

Review 6.  A Systematic Review of the Circadian Rhythm of Bone Markers in Blood.

Authors:  Sarah Seberg Diemar; Stig Søgaard Dahl; Anders Sode West; Sofie Amalie Simonsen; Helle Klingenberg Iversen; Niklas Rye Jørgensen
Journal:  Calcif Tissue Int       Date:  2022-03-19       Impact factor: 4.333

Review 7.  Biochemical assessment of bone turnover and bone fragility in men.

Authors:  P Szulc; J M Kaufman; P D Delmas
Journal:  Osteoporos Int       Date:  2007-06-14       Impact factor: 4.507

8.  Effect of Ramadan fasting in Saudi Arabia on serum bone profile and immunoglobulins.

Authors:  Suhard M Bahijri; Ghada M Ajabnoor; Anwar Borai; Jumana Y Al-Aama; George P Chrousos
Journal:  Ther Adv Endocrinol Metab       Date:  2015-10       Impact factor: 3.565

9.  The contribution of serum cortisone and glucocorticoid metabolites to detrimental bone health in patients receiving hydrocortisone therapy.

Authors:  Rosemary Dineen; Lucy-Ann Behan; Grainne Kelleher; Mark J Hannon; Jennifer J Brady; Bairbre Rogers; Brian G Keevil; William Tormey; Diarmuid Smith; Christopher J Thompson; Malachi J McKenna; Wiebke Arlt; Paul M Stewart; Amar Agha; Mark Sherlock
Journal:  BMC Endocr Disord       Date:  2020-10-10       Impact factor: 2.763

10.  Diurnal Rhythms of Bone Turnover Markers in Three Ethnic Groups.

Authors:  Jean Redmond; Anthony J Fulford; Landing Jarjou; Bo Zhou; Ann Prentice; Inez Schoenmakers
Journal:  J Clin Endocrinol Metab       Date:  2016-06-13       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.